ASCENTAGE PHARMA
Live / Registered — Registered — Section 71 accepted (as of 12 Sept 2026)
What this means for you
Registered since 08 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79246610
- Registration number
- 5876589
- Mark type
- Stylized text
- Filed
- 10 Aug 2018
- Published for opposition
- 23 Jul 2019
- Registered
- 08 Oct 2019
- Attorney of record
- Kathryn E. Smith
Goods and services
- Class 005 — Pharmaceuticals: Medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; [ bacterial poisons; ] pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; [ chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; ] drugs for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease [ ; medicines for dental purposes; antibiotics; pharmaceutical preparations in the form of injection for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations in the form of tablet for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; active pharmaceutical ingredients in the nature of drug delivery agents in the form of powders, liquids, and capsules that provide controlled release of active ingredients for a wide variety of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; active pharmaceutical ingredients for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antiseptics; collyrium; suppositories; medicinal oils; transdermal patches for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; candy, medicated; candy for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic substances adapted for medical use; mineral food supplements; nutritional supplements ]
Owner
Prosecution history
- 12 Sept 2026 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 12 Sept 2026 — REGISTERED-SEC.71 ACCEPTED
- 27 Jul 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Apr 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 07 Apr 2026 — TEAS SECTION 71 RECEIVED
- 07 Nov 2025 — CHANGE OF OWNER RECEIVED FROM IB
- 21 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Aug 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 21 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Aug 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Aug 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Oct 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 01 Apr 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 01 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED